Ammonium tetrathiomolybdate treatment of copper-associated hepatopathy in dogs.

Daniel K LangloisJanice R QuerubinWilliam D SchallNathan C NelsonRebecca C Smedley

Published in: Journal of veterinary internal medicine (2019)

Results suggest that TTM can effectively decrease [Cu]H in some dogs with CAH. Larger studies are needed to determine the overall safety and efficacy of TTM for treating CAH and how it compares with current treatments.

Keyphrases

case control
metal organic framework
oxide nanoparticles